Most financial analysts will agree that the best pharmaceutical stocks offer indelible relevance for your portfolio. As an example, picking out the most viable consumer discretionary stock is a ...

Teva reported fourth-quarter revenue of $4.2 billion, beating analyst estimates of $4.13 billion, according to Benzinga Pro. The company reported fourth-quarter adjusted earnings of 71 cents per share ...